ACELRX PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAcelrx Pharmaceuticals Inc • August 31st, 2012 • Pharmaceutical preparations • New York
Company FiledAugust 31st, 2012 Industry JurisdictionAcelRx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows: